Glenn Coleman
CIK: 0001434369
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Sep 30, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Purchase(P)Direct10 shares at avg. $297.43$3K - May 29, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Award(A)Direct6.6K shares at avg. $180.71$1.2M - May 1, 2026CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Award(A)Direct21.1K shares at avg. $165.78$3.5M - Nov 25, 2025PINC
Premier, Inc.
Disposition(D)Direct161.5K shares at avg. $28.25$4.6M - Nov 25, 2025PINC
Premier, Inc.
Disposition(D)Direct32K shares- - Nov 11, 2025PINC
Premier, Inc.
Tax Payment(F)Direct17K shares at avg. $28.17$480K - Nov 11, 2025PINC
Premier, Inc.
Tax Payment(F)Direct3.9K shares at avg. $28.17$109K - Aug 21, 2025PINC
Premier, Inc.
Award(A)Direct32K shares- - Aug 19, 2025PINC
Premier, Inc.
Award(A)Direct23.9K shares- - Aug 19, 2025PINC
Premier, Inc.
Award(A)Direct15K shares- - Nov 11, 2024PINC
Premier, Inc.
Award(A)Direct143.5K shares- - Oct 11, 2024XRAY
DENTSPLY SIRONA Inc.
Award(A)Direct375 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Purchase(P) | 10 | $297.43 | $2,974 | Direct |
| May 29, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award(A) | 6,640 | $180.71 | $1,199,914 | Direct |
| May 1, 2026 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Award(A) | 21,112 | $165.78 | $3,499,947 | Direct |
| Nov 25, 2025 | PINC Premier, Inc. | Disposition(D) | 161,464 | $28.25 | $4,561,358 | Direct |
| Nov 25, 2025 | PINC Premier, Inc. | Disposition(D) | 32,018 | - | - | Direct |
| Nov 11, 2025 | PINC Premier, Inc. | Tax Payment(F) | 17,026 | $28.17 | $479,622 | Direct |
| Nov 11, 2025 | PINC Premier, Inc. | Tax Payment(F) | 3,874 | $28.17 | $109,131 | Direct |
| Aug 21, 2025 | PINC Premier, Inc. | Award(A) | 32,018 | - | - | Direct |
| Aug 19, 2025 | PINC Premier, Inc. | Award(A) | 23,888 | - | - | Direct |
| Aug 19, 2025 | PINC Premier, Inc. | Award(A) | 15,001 | - | - | Direct |
| Nov 11, 2024 | PINC Premier, Inc. | Award(A) | 143,475 | - | $0 | Direct |
| Oct 11, 2024 | XRAY DENTSPLY SIRONA Inc. | Award(A) | 375 | - | $0 | Direct |
1-12 of 12 transactions
About Coleman Glenn
Coleman Glenn (SEC CIK 0001434369) files insider reports with the SEC as EVP & Chief Financial Officer of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), CAO & CFO of Premier, Inc. (PINC) and Executive VP & CFO of DENTSPLY SIRONA Inc. (XRAY).
Signal8 holds 11 ownership filings by Coleman Glenn (2 Form 3, 9 Form 4), filed between Oct 15, 2024 and Oct 2, 2026. Those filings report 12 transactions, from Oct 11, 2024 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Coleman Glenn's filings is in WILMINGTON, MA.
Recent filings by Coleman Glenn
- Sep 30, 2026: Open-market purchase of CRL shares (Form 4, code P).
- May 29, 2026: Grant or award of CRL shares (Form 4, code A).
- May 1, 2026: Grant or award of CRL shares (Form 4, code A).
- Nov 25, 2025: Disposition to issuer transactions of PINC shares (2 lines, Form 4, code D).
- Nov 11, 2025: Tax withholdings of PINC shares (2 lines, Form 4, code F).
Other insiders filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
- FOSTER JAMES C, Director
- Parisotto Shannon M, CEVP, Disc & Safety Assessment
- Girshick Birgit, Chief Executive Officer
- Andrews Nancy C, Director
- LaPlume Joseph W, EVP, Corp Strategy & Develop
- Knell Michael Gunnar, SVP, Finance and CAO